View in EDS HTML Full Text PDF Full Text

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.

Saved in:
Bibliographic Details
Title: CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.
Authors: Accolla RS; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Ramia E; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Tedeschi A; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Forlani G; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.
Source: Frontiers in immunology [Front Immunol] 2019 Jul 30; Vol. 10, pp. 1806. Date of Electronic Publication: 2019 Jul 30 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31417570
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Accolla+RS%22">Accolla RS</searchLink>; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.<br /><searchLink fieldCode="AU" term="%22Ramia+E%22">Ramia E</searchLink>; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.<br /><searchLink fieldCode="AU" term="%22Tedeschi+A%22">Tedeschi A</searchLink>; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.<br /><searchLink fieldCode="AU" term="%22Forlani+G%22">Forlani G</searchLink>; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2019 Jul 30; Vol. 10, pp. 1806. <i>Date of Electronic Publication: </i>2019 Jul 30 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31417570
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2019.01806
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1806
    Titles:
      – TitleFull: CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Accolla RS
      – PersonEntity:
          Name:
            NameFull: Ramia E
      – PersonEntity:
          Name:
            NameFull: Tedeschi A
      – PersonEntity:
          Name:
            NameFull: Forlani G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 07
              Text: 2019 Jul 30
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1